Bayer Stock Crashes After Monsanto Cancer Verdict Upheld By Judge; Analyst Estimates $800 Billion In Future Liability

By Sayer Ji, Wake Up World

Bayer greedily bought and swallowed the ‘poison pill’ of Monsanto without considering its true liability. Fifty-seven billion Euros of market cap down the drain later, now their headache is taking on epic proportions…

Growing uncertainty about how San Francisco Superior Court Judge Suzanne Ramos Bolanos would rule in Bayer’s appeal of the Monsanto cancer verdict was resolved Tuesday morning, as the judge upheld the jury’s decision that the glyphosate-based weedkiller (Roundup) sold by Monsanto caused a California man’s terminal cancer and that Monsanto intentionally hid its dangers.

The news quickly spread and caused an immediate crash in Bayer’s stock value, sending a powerful message to the Agrochemical industry that they are legally and financially responsible for the adverse effects caused by their unscrupulously marketed products despite receiving a regulatory pass from government agencies like the EPA, USDA, and FDA that have traditionally acted as industry cheerleaders.

The judge decided to reduce the punitive damage award from the original total of $289 million following a verdict reached earlier this summer, down to $78.5 million — a decision which concerned jurors who decided on the higher award amount in order to send a clear message to Monsanto that they deserve to be punished for covering up the dangers of their herbicide.

The good news is that this ruling affirms the company’s liability for causing illness from their product, and opens the door for more lawsuits and stricter regulation of agrochemicals in the future. Ian Hilliker, an analyst at Jefferies LLC in London, estimated in a note to clients that based on a class action lawsuit involving 8,700 plaintiffs believed to have cancer as a result of glyphosate exposure, Monsanto’s liability could reach $800 billion dollars. To put this in perspective, the original Bayer-Monsanto buyout offer was $57 billion dollars. Clearly, Monsanto no longer looks like an “asset” to Bayer and its stockholders.

bayer-stock-crashes-monsanto-cancer-verdict-judge-billion-liability-2

In the tweet above, German analyst Holder Zschaepitz points out that Bayer’s Monsanto acquisition may have precipitated the largest destruction of market capitalization in German stock market history, standing at about 57.7 billion Euros in losses thus far.

Learn more about Bayer’s history in the video below, produced by independent media site The Corbett Report.

Note: The case is Johnson v. Monsanto Co., CGC-16-550128, California Superior Court, County of San Francisco (San Francisco).

The Last Word

“It’s no surprise that Monsanto kept secrets from Bayer. Johnson’s jury heard evidence that for four decades Monsanto maneuvered to conceal Roundup’s carcinogenicity by capturing regulatory agencies, corrupting public officials, bribing scientists and engaging in scientific fraud to delay its day of reckoning. The jury found that these activities constituted “malice, fraud and oppression” warranting $250 million in punitive damages.

“I am one of several attorneys representing, collectively, now some 8,000 clients with similar cases… For Bayer the worst is yet to come.”

— Robert F. Kennedy, Jr.

Sources: 

  • Wall Street Journal: Judge Reduces Jury Award Against Bayer’s Roundup to $78.5 Million
  • Bloomberg: Bayer Runs Into ‘Devil’s Advocate’ in Roundup Cancer Case
  • Health Impact NewsJudge Says She Will Overturn Jury Conviction of Monsanto and Nullify $250 Million Award in Damages Over Glyphosate Injuries

Recommended articles by Sayer Ji: 

About the author:

sayer-ji-bio-350x3501Sayer Ji is the founder of Greenmedinfo.com, a reviewer at the International Journal of Human Nutrition and Functional Medicine, Co-founder and CEO of Systome Biomed, Vice Chairman of the Board of the National Health Federation, and Steering Committee Member of the Global Non-GMO Foundation.

For more, visit GreenMedInfo.com and Facebook.com/GreenMedInfo, or sign up for GreenMedInfo’s free e-Newsletter.

© October 23rd, 2018 GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for their newsletter here.

Advertisements

Share your thoughts

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.